A Protecting-Group-Free S‑Glycosylation Strategy for Complex S‑Glycopeptide Synthesis Authors: Ge Gao, Jinsheng Lai, Jiale Chen, Yutian Wang, Qingju Zhang, Qi Zhang Published: 2026 ABSTRACT Protecting-group (PG)-free S-glycosylation offers an attractive strategy for glycopeptide synthesis, yet practical methods for complex peptides remain limited. Here, we report a non-photochemical S-glycosylation strategy that directly couples unprotected glycosyl donors with unprotected cysteine-containing peptides, enabling efficient access to β-S-glycopeptides. The method shows broad compatibility with glycosyl donors and peptide substrates and enables direct glycosylation of a structurally complex 37-mer precursor bearing one free cysteine, four protected cysteines, and oxidation-sensitive functionalities, thereby facilitating the efficient synthesis of sublancin and diverse glycosylated analogues. In contrast to photochemical radical-based S-glycosylation, which produces α-S-glycopeptides and proved unsuitable for the full-length substrate, the present strategy allows efficient late-stage glycosylation of structurally complex peptides. Combined with a fragment-based native chemical ligation approach for α-S-glycoside synthesis, this platform provides stereochemically defined sublancin analogues and reveals that the configuration of the S-glycosidic linkage strongly influences antibacterial activity. These results establish a practical PG-free platform for complex S-glycopeptide synthesis and glycocin structure–activity studies. Glycosylation of peptides and proteins plays central roles in molecular recognition, immune regulation, and cellular signaling. , Among these molecules, S-linked glycans have attracted increasing interest as hydrolytically stable mimetics of natural O-glycans and as useful probes for studying glycoprotein structure and function. , Previous studies have shown that S-glycosides can reproduce key structural and biological features of O-glycosides while displaying enhanced resistance toward enzymatic and chemical degradation. Moreover, S-glycosylation is a defining structural feature of glycocins, an emerging class of ribosomally synthesized and post-translationally modified peptides (RiPPs) with promising pharmaceutical and agricultural potential, − as represented by the prototypical member sublancin (1). Protecting-group (PG)-free S-glycosylation provides an attractive strategy for the late-stage preparation of structurally defined glycopeptides and glycoprotein mimetics. Early studies by Shoda and coworkers demonstrated that unprotected sugars could be directly converted into aryl thioglycosides under aqueous conditions using DMC-mediated activation. Miller and coworkers subsequently demonstrated calcium-promoted activation of unprotected glycosyl fluorides for the O-glycosylation of sucrose, small molecules, and complex unprotected peptides in aqueous media. , Although these studies focused on oxygen nucleophiles, they established the utility of unprotected glycosyl fluorides for the direct glycosylation of structurally complex substrates. More recently, Koh, Davis, and coworkers reported a radical-based strategy for direct functionalization of native sugars including S-glycosides. For S-glycopeptide synthesis, Li and coworkers reported a β-selective coupling strategy using unprotected glycosyl fluorides and Ca­(OH)2 in water, enabling the synthesis of thioglycosides and short thioglycopeptides (Figure A). The method was demonstrated mainly with small thiols and short peptide substrates; for the synthesis of the sublancin-derived glycopeptide fragment, the peptide acceptor carried an N-terminal Boc protecting group. However, whether this chemistry could be directly extended to long and structurally complex peptide substrates remained unclear. Niu and coworkers developed a photochemical radical-based platform for peptide and protein S-glycosylation using unprotected allyl glycosyl sulfones, providing highly stereoselective access to α-S-glycopeptides (Figure B). , Despite these advances, practical methods for direct β-S-glycosylation of structurally complex peptide substrates remain limited, particularly for long and complex cysteine-containing peptides. In this study, we developed an efficient PG-free strategy for the synthesis of β-S-glycopeptides under mild non-photochemical conditions, enabling direct late-stage glycosylation of structurally complex cysteine-rich peptide substrates (Figure C). Evolution of PG-free strategies for peptide S-glycosylation. (A) Base-promoted β-selective S-glycosylation of short peptide acceptors using unprotected glycosyl fluorides developed by Li and co-workers. (B) Photochemical radical-based α-selective S-glycosylation developed by Niu and co-workers. (C) This work: a non-photochemical PG-free strategy for late-stage β-S-glycosylation of complex cysteine-rich peptide substrates. To establish an efficient approach for PG-free peptide S-glycosylation, we selected glutathione as a model peptide. Initial evaluation under low reagent loadings resulted in incomplete conversion and substantial disulfide formation. We therefore systematically investigated the effects of the base, solvent composition, and reaction temperature. The combination of Ca­(OH)2 with 25% DMSO in water substantially improved the reaction outcome (Table ). Further increasing the temperature to 50 °C markedly accelerated the desired S-glycosylation, affording the β-S-glycopeptide in excellent yield within 1 h. These optimized conditions provide a practical, non-photochemical platform for direct β-S-glycosylation of unprotected cysteine-containing peptides. 1Optimization of Glutathione S-Glycosylation through Systematic Evaluation of Glycosyl Donors, Bases, Solvent Systems, and Reaction Temperatures EntryRBaseSolventTemp/°CYield/%1FKOHH2Or.t.02FLiOHH2Or.t.03FBa(OH)2 H2Or.t.04FCaCO3 H2Or.t.05FCaOH2Or.t.<106FCa(OH)2 H2Or.t.307FCa(OH)2 DMSOr.t.168FCa(OH)2 MeOHr.t.09FCa(OH)2 MeCNr.t.010FCa(OH)2 MeOH:H2O = 1:1r.t.<511FCa(OH)2 MeCN:H2O = 1:1r.t.<512FCa(OH)2 DMSO:H2O = 1:1r.t.2713FCa(OH)2 DMSO:H2O = 1:2r.t.3914FCa(OH)2 DMSO:H2O = 1:3r.t.5315FCa(OH)2 DMSO:H2O = 1:3407116FCa(OH)2 DMSO:H2O = 1:3509117FCa(OH)2 DMSO:H2O = 1:3606918BrCa(OH)2 DMSO:H2O = 1:350<1019ClCa(OH)2 DMSO:H2O = 1:350<10aThe reactions were performed with 0.1 mmol 2, 0.11 mmol 3 and base for 1 h. Optimization of Glutathione S-Glycosylation through Systematic Evaluation of Glycosyl Donors, Bases, Solvent Systems, and Reaction Temperatures The reactions were performed with 0.1 mmol 2, 0.11 mmol 3 and base for 1 h. With the optimized conditions established, we next examined the scope of S-glycosylation using structurally diverse glycosyl fluoride donors and cysteine-containing peptide substrates (Table ). A range of unprotected glycosyl fluorides, including glucose-, galactose-, and glucosamine-derived donors, were synthesized (Supporting Information Methods). Subsequent reactions showed these glycosyl donors were readily coupled to peptide thiols under the optimized conditions, affording the corresponding S-glycopeptides in generally good to excellent yields (Table , entry 1–4). The reaction was also compatible with basic and acidic cysteine-containing oligopeptides (Table , entry 5–6). 2Scope of the PG-Free S-Glycosylation with Structurally Diverse Glycosyl Fluoride Donors and Cysteine-Containing Peptides Scope of the PG-Free S-Glycosylation with Structurally Diverse Glycosyl Fluoride Donors and Cysteine-Containing Peptides To evaluate the efficiency of multiple S-glycosylation events within a single peptide, we examined peptide substrates 9 and 12, each containing two unprotected cysteine residues located at the N- and C-terminal regions (Table , entries 7 and 8). Both substrates were efficiently converted to the corresponding diglycosylated products in 77% and 74% yields, respectively. Minor amounts of monoglycosylated products were also detected. HR-MS/MS analysis revealed that these products comprised mixtures glycosylated at either cysteine residue (Figures S1–S2), indicating that the reaction exhibits little intrinsic site selectivity among multiple unprotected cysteines. These results further demonstrate that the method efficiently modifies cysteine residues at different positions and chemical environments. To determine whether the method could accommodate glycosyl donors beyond monosaccharides, we synthesized two unprotected disaccharide glycosyl fluorides, 3e and 3f, and evaluated them under the optimized conditions. Both donors underwent efficient S-glycosylation, affording the corresponding glycopeptides in 86% and 84% yields, respectively (Table , entries 9 and 10). These results extend the donor scope of the reaction to disaccharide donors. Together with the peptide-substrate studies, these results demonstrate that the method tolerates substantial variation in both the glycosyl donor and the cysteine-containing peptide acceptor under PG-free conditions. We next asked whether this reactivity could be translated from short model peptides to the late-stage modification of a structurally demanding glycopeptide precursor. Sublancin, the prototypic member of the glycocin natural product family, was selected as a stringent test case. Sublancin contains a native β-S-glucosyl cysteine residue and two disulfide bonds (Figure ), and previous studies have established that the S-linked glycan is essential for its antibacterial activity. − To synthesize sublancin, we prepared a 37-mer peptide bearing one free cysteine for glycosylation, while the remaining 4 cysteines were masked with orthogonal acetamidomethyl (Acm) protecting groups for subsequent disulfide formation. Indeed, direct glucosylation under the optimized conditions furnished the desired β-S-glucosylated precursor in excellent yield (91%), which was then converted to sublancin by in situ deprotection and oxidative folding. The β-glycosidic linkage of the resulting sublancin was established by 1H–1H COSY analysis, in which no obvious correlation signal between the anomeric proton (H1′) and H2′ was observed (Figures S3–S4), which is in stark contrast to the strong correlation of the corresponding hydrogens in the α-variant (vide infra). PG-free glycosylation strategy for late-stage synthesis and diversification of sublancin analogues, showing synthetic route for direct β-S-glycosylation of the full-length sublancin precursor to access structurally diverse sublancin analogues, and antibacterial activities of sublancin analogues determined by MIC assays against Bacillus subtilis CGMCC 1.3358. We applied this strategy to access structurally diverse sublancin analogues by changing the glycosyl donor. A panel of β-S-glycosylated sublancin variants bearing distinct carbohydrate units, including galactosyl, N-acetylglucosaminyl (GlcNAc), and 6-dansyl-glucosyl groups (Glc-6-Dan, a glucosyl group bearing a dansyl substituent at O6), was readily prepared from a common peptide precursor. This late-stage diversification strategy is in contrast to previous chemical syntheses of sublancin, , or related glycocin F, which relied on individually preassembled glycosylated cysteine building blocks and required repetitive peptide synthesis for each analogue. Our approach also complements the enzymatic glycosylation platform developed by van der Donk and coworkers, − which could be constrained by enzyme substrate recognition and less amenable to the incorporation of structurally divergent glycans (e.g., Glc-6-Dan investigated in this study). Antibacterial evaluation of the resulting sublancin analogues against Bacillus subtilis CGMCC 1.3358 showed that the galactosyl analogue (16) retained activity comparable to that of native sublancin, whereas the GlcNAc analogue (17) exhibited an approximately 5-fold reduction in antibacterial potency. These observations are consistent with previous studies by van der Donk and coworkers showing that sublancin tolerates variation in the attached glycan moiety while largely retaining antibacterial activity. In contrast, no detectable antibacterial activity was observed for the Glc-6-Dan analogue (18), suggesting that substantial enlargement of the glycan moiety is detrimental to the antibacterial activity of sublancin. Previous studies have established that the antibacterial activity of sublancin depends on an active phosphoenolpyruvate:sugar phosphotransferase system (PTS), although the specific PTS component involved remains unclear. ,, To obtain a structural hypothesis, we modeled sublancin with the PTS components PtsG, PtsH, and PtsI using AlphaFold 3. Among the components examined, only the glucose-specific EIICBA transporter PtsG yielded a plausible sublancin-associated model, in which the peptide contacted the N-terminal region of PtsG (Figure S5). We therefore used this predicted Ser–Glc sublancin–PtsG complex as the starting structure for MD simulations to examine the persistence of the modeled interface. We performed 1 μs explicit-solvent MD simulations using a Ser–Glc surrogate of sublancin bound to PtsG1–422. Throughout the trajectory, the β-glucosylated complex retained persistent peptide–PtsG and glycan–PtsG contacts, while the receptor RMSD reached a stable plateau (Figures A and S6). The trajectory-averaged nonbonded interaction descriptor also remained favorable over the simulation (Figure S7). These analyses indicate that the representative snapshot shown in Figure B reflects a persistent modeled interface rather than a transient configuration selected from a single MD frame. In this model, the glucose moiety remained associated with a compact glycan-contacting region of PtsG (Figure B). This feature provides a possible structural rationale for the loss of activity of the Glc-6-Dan analogue, because the bulky 6-O-dansyl substituent may be less readily accommodated within this region. Explicit-solvent MD analysis of sublancin binding to the PTS component PtsG using a Ser-Glc computational surrogate. (A) Receptor RMSD profiles of the α- and β-glucosylated complexes during the 1 μs simulations. Both trajectories reached relatively stable plateaus, whereas the α-glucosylated complex exhibited higher RMSD values and greater structural fluctuations than the β-glucosylated complex. (B) Representative snapshot of the β-glucosylated sublancin–PtsG complex selected from the equilibrated trajectory. PtsG residues within 5.5 Å of the glucose moiety are shown to illustrate the modeled glycan-contacting region. The structural interpretation is based on the complete trajectory rather than this individual frame. Motivated by these observations, we next sought to investigate whether the stereochemistry of the S-glycosidic linkage itself influences glycocin activity. Because the present glycosyl fluoride-based strategy afforded β-S-glycosides, access to the corresponding α-S-glucosyl sublancin analogue required a complementary synthetic approach. We turned to the photochemical radical-based α-S-glycosylation strategy developed by Niu and coworkers. However, direct application of the photochemical conditions to the full-length sublancin precursor 15 resulted in poor conversion with substantial peptide decomposition (Figure A). We therefore adopted a fragment-based strategy in which α-S-glycosylation was first performed on a peptide fragment, followed by peptide assembly by native chemical ligation to furnish the corresponding α-S-glucosylated sublancin analogue (19) (Figure B). The α-glycosidic linkage in 19 was unambiguously established by the strong correlation (J = 4.2 Hz) between proton (H1′) and H2′ in the anomeric region H–H COSY analysis (Figures S8–S9). Synthesis of the α-S-glucosyl analogue of sublancin. (A) Direct photochemical S-glucosylation of the full-length sublancin precursor failed to afford the desired product, likely owing to photodegradation of the long cysteine-containing precursor peptide under the radical reaction conditions. (B) Synthesis of the α-S-glucosylated analogue 19 through a fragment-based strategy involving photochemical S-glycosylation of a short peptide fragment followed by native chemical ligation, deprotection, and oxidative folding. Intriguingly, the α-S-glucosylated analogue 19 also retained extensive contacts with PtsG throughout the 1 μs MD simulation, indicating that inversion of the anomeric configuration did not abolish the modeled association (Figure S10). However, the α-glucosylated complex exhibited consistently higher receptor RMSD values and greater structural fluctuations than the β-glucosylated sublancin complex (Figure A). This increased conformational variability is consistent with the lack of detectable antibacterial activity of 19 under the tested conditions. Nevertheless, the simulations alone do not establish a causal relationship between the increased structural fluctuations and the loss of activity. These results suggest that the configuration of the S-glycosidic linkage may influence the dynamics and organization of the modeled sublancin–PtsG complex, although further experimental studies will be required to define the underlying mechanism. In summary, we developed an efficient PG-free strategy for peptide β-S-glycosylation using unprotected glycosyl donors and cysteine-containing peptides under non-photochemical conditions. The method displays broad substrate compatibility and is sufficiently robust for late-stage glycosylation of structurally complex cysteine-rich glycocin precursors. This strategy enabled rapid access to diverse sublancin analogues directly from a common peptide precursor, thereby facilitating structure–activity relationship studies of this important glycocin family member. Moreover, the pronounced dependence of antibacterial activity on S-glycosidic stereochemistry establishes glycan geometry as a critical determinant of glycocin recognition and function. More broadly, the present strategy should facilitate future studies in glycocin engineering, glycopeptide chemical biology, and late-stage diversification of glycosylated peptide natural products. Supplementary Material